瑞雷治疗

关于 Relay Therapeutics

Relay Therapeutics, Inc. 从事 transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology. Its Dynamo 平台 is use to integrate an array of edge experimental and computational approaches, which allows to apply the understanding of protein structure and motion to drug discovery. The company was 成立 by David Elliot Shaw, Matthew P. Jacobson, Dorothee Kern, Mark Murcko, Alexis Borisy, and Jakob Loven on May 4, 2015 and is 总部位于 in Cambridge, MA.

成立时间

2015

首席执行官

Dr. Sanjiv K. Patel, M.B.B.S.,M.D.

员工人数

192

总部地址

Cambridge, Massachusetts, United States of America

财年结束日

12-31

官方网站

relaytx.com

公司概况

交易所

US

股票代码

RLAY

市值排名

#2273

上市日期

2020-07-16

市值

3.57B

流通市值

2.37B

总股数

219.14M

流通股数

145.55M

行业与主题板块

浏览全部行业与主题板块